The present invention relates to a novel pharmaceutical formulation of the active ingredient dabigatran etexilate of formula I, which may be in the form of its pharmaceutically acceptable salt, as well as its preparation.本発明は、薬学的に許容可能なその塩の形態であってもよい、式Iの有効成分ダビガトランエテキシレートの新規の医薬製剤、ならびにその調製に関する。